Human T-cell lymphotropic virus type 1 Gag indeterminate western blot patterns in Central Africa: Relationship to Plasmodium falciparum infection

Journal of Clinical Microbiology

Volumn 38, Issue 11, 2000, Pages 4049-4057

  Mahieux, R ^a   Horal, P ^a   Mauclere P ^a   Mercereau Puijalon, O ^a   Guillotte, M ^a   Meertens, L ^a   Murphy, E ^a   Gessain, A ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; EPITOPE; GAG PROTEIN; PARASITE ANTIGEN; PROTEIN P19; PROTEIN P300;

ANTIBODY TITER; ARTICLE; CARBOXY TERMINAL SEQUENCE; CENTRAL AFRICA; CONTROLLED STUDY; CROSS REACTION; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; IMMUNOFLUORESCENCE TEST; MALARIA; MONONUCLEAR CELL; NONHUMAN; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VERTICAL TRANSMISSION; VIRUS ISOLATION; WESTERN BLOTTING;

HTLV; HTLV 1; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2; PLASMODIUM FALCIPARUM; PROTOZOA; RNA VIRUSES;

EID: 0034460084     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.38.11.4049-4057.2000     Document Type: Article

References (60)

1. Acquired immunodeficiency syndrome (AIDS). Proposed WHO criteria for interpreting results from western blot assays for HIV-1, HIV-2, and HTLV-I/HTLV-II
2. Seroepidemiology of the human T-cell leukaemia/lymphoma viruses in Europe
3. Antibodies to HTLV-I in populations of the southwestern Pacific
4. Human T-cell lymphotropic virus (HTLV)-related endogenous sequence, HRES-1, encodes a 28-kDa protein: A possible autoantigen for HTLV-I gag-reactive autoantibodies
5. ELISA HTLV retrovirus antibody reactivity associated with malaria and immune complexes in healthy Africans
6. The prevalence of antibodies to the human T lymphotropic virus (HTLV) in Ghana, West Africa
7. Type-I HTLV antibody in urban and rural Ghana, West Africa
8. HTLV-I in Burundi (east Africa): Lack of reactivity to the HTLV-I immunodominant envelope epitope
9. Accuracy of supplementary serologic testing for human T-lympotropic virus types I and II in US blood donors
10. Absence of evidence of infection with divergent primate T-lymphotropic viruses in United States blood donors who have seroindeterminate HTLV test results
11. Comparison of six commercial human T-cell lymphotropic virus type I (HTLV-I) enzyme immunoassay kits for detection of antibody to HTLV-I and -II
12. Seroepidemiology of HTLV-I/II in universal screening of blood donations in France
13. Absence of human T-lymphotropic virus type I tax sequences in a population of normal blood donors in the Baltimore, MD/Washington, DC, area: Results from a multicenter study
14. Epidemiology of HTLV-I in Gabon (Western Equatorial Africa)
15. Seroepidemiological survey of HTLV-I infection among randomized populations of western central African countries
16. Comparative seroepidemiology of HTLV-I and HTLV-III in the French West Indies and some African countries
17. Seroepidemiology of human T-cell lymphotropic virus type I/II in Benin (West Africa)
18. Comparison of four enzyme immunoassays for detection of human T-cell lymphotropic virus type 2 antibodies
19. HTLV-I/II infection in a high viral endemic area of Zaire, Central Africa: Comparative evaluation of serology, PCR, and significance of indeterminate western blot pattern
20. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis
21. HTLV-I "indeterminate" Western blot patterns observed in sera from tropical regions: The situation revisited
22. Antibodies to human T lymphotropic virus type I in a population from the Philippines: Evidence for cross-reactivity with Plasmodium falciparum
23. Monoclonal antibody against human T cell leukemia virus p19 defines a human thymic epithelial antigen acquired during ontogeny
24. Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides
25. Indeterminate HTLV serologic results in U.S. blood donors: Are they due to HTLV-I or HTLV-II?
26. Low incidence of HTLV infections in random blood donors with indeterminate western blot patterns
27. Delineation of immunodominant epitopes of human T-lymphotropic virus types I and II and their usefulness in developing serologic assays for detection of antibodies to HTLV-I and HTLV-II
28. Sensitivity and specificity of a recombinant transmembrane glycoprotein (rgp21)-spiked western immunoblot for serological confirmation of human T-cell lymphotropic virus type I and type II infections
29. Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy
30. Human T lymphotropic virus type I/II in Lake Lindu Valley, Central Sulawesi, Indonesia
31. Immunologic cross-reactivity between structural proteins of human T-cell lymphotropic virus type I and the blood stage of Plasmodium falciparum
32. Failure to detect evidence of human T-lymphotropic virus (HTLV) type I and type II in blood donors with isolated gag antibodies to HTLV-I/II
33. Characterization of immunodominant epitopes of gag and pol gene-encoded proteins of human T-cell lymphotropic virus type I
34. Plasmodium falciparum: Altered expressions of erythrocyte membrane-associated antigens during antigenic variation
35. Significance of human T-lymphotropic virus type I indeterminant serological findings among healthy individuals
36. Epidemiological features of retroviral infection by HTLV-1 in central Africa
37. Human endogenous retroviruslike genome with type C pol sequences and gag sequences related to human T-cell lymphotropic viruses
38. The tax mutation at nucleotide 7959 of human T-cell leukemia virus type 1(HTLV-1) is not associated with tropical spastic paraparesis/HTLV-1-associated myelopathy but is linked to the cosmopolitan molecular genotype
39. Molecular characterization and phylogenetic analyses of a new, highly divergent simian T-cell lymphotropic virus type 1 (STLV-1marcl) in Macaca arctoides
40. Demographic, ethnic, and geographic differences between human T cell lymphotropic virus (HTLV) type I-seropositive carriers and persons with HTLV-I Gag-indeterminate Western blots in Central Africa
41. Sexual transmission of human T-lymphotropic virus type I (HTLV-I)
42. Human T-lymphotropic virus type I (HTLV-I) seroprevalence in Jamaica. I. Demographic determinants
43. Failure to isolate human T cell lymphotropic virus type I and to detect variant-specific genomic sequences by polymerase chain reaction in Melanesians with indeterminate western immunoblot
44. Monoclonal antibodies reactive with human T cell lymphotropic virusI (HTL VI) p19 internal core protein: Cross-reactivity with normal tissues and differential reactivity with HTLV types I and II
45. Characterization of an antigen shared by human thymic epithelium and human T cell leukemia virus p19 Gag protein
46. Detection and cloning of new HTLV-related endogenous sequences in man
47. HTLV-I/II indeterminate serology and natural killer cell expansion
48. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma
49. Immune response against the exp-1 protein of Plasmodium falciparum results in antibodies that cross-react with human T-cell lymphotropic virus type 1 proteins
50. Mapping of a human T-lymphotropic virus type I gag protein epitope that cross-reacts with anti-Plasmodium falciparum antibodies
51. Evidence for anti-Plasmodium falciparum antibodies that cross-react with human T-lymphotropic virus type I proteins in a population in Irian Jaya, Indonesia
52. HTLV-I antibody studies in villagers in East Sepik Province, Papua New Guinea
53. Human sera from varicella-zoster virus (VZV) infections cross-react with human T cell leukaemia virus type 1 (HTLV-1): Common epitopes in VZV gene 22 protein and HTLV-1 p19 gag protein
54. Human T-cell leukemia virus (HTLV-I) antibodies in Africa
55. HTLV-I/II seroindeterminate Western blot reactivity in a cohort of patients with neurological disease
56. Examination of HTLV-I ELISA-positive leukemia/lymphoma patients by western blotting gave mostly negative or indeterminate reaction
57. Low HTLV-I/II seroprevalence in pregnant women in Congo and a geographic cluster of an HTLV-like indeterminate Western blot pattern
58. Prevalence of antibody to human T cell leukemia virus type 1 (HTLV-1) in populations of Ivory Coast, West Africa
59. Characterization and sequencing of prototypic human T-lymphotropic virus type 1 (HTLV-1) from an HTLV-1/2 seroindeterminate patient
60. Human T lymphotropic virus type I infection in Papua New Guinea: High prevalence among the Hagahai confirmed by western analysis